S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
pixel
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
pixel
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
pixel
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
pixel
Log in
OTCMKTSMKTS:OMRX

Orthometrix Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume6,556 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta0.74
Orthometrix, Inc. develops technologies, procedures, and devices to help increase musculoskeletal mobility, as well as non-invasive technologies to treat the pain associated with osteoarthritis, plantar fasciitis, and other musculoskeletal conditions that reduce mobility. The company markets, sells, and services peripheral quantitative computed tomography bone and muscle measurement systems for research and clinical applications; patented motorized exercise systems for rehabilitation, physical therapy, and sports medicine based on patented vibration technology; human performance measurement systems for monitoring improvement in power and mobility; and extracorporeal shock wave therapy systems for non-invasive treatment of pain associated with plantar fasciitis. It also markets, sells, and services patented motorized exercise systems to professional teams, fitness centers, gyms, sports clubs, and wellness-conscious general public. The company offers bone and muscle diagnostic, bone and muscle research, rehabilitation/physical therapy, sports and fitness, and home products. It serves healthcare, veterinary, and sports and fitness markets in the United States and internationally. The company was formerly known as Norland Medical Systems, Inc. and changed its name to Orthometrix, Inc. in April 2002. Orthometrix, Inc. was founded in 1993 and is headquartered in Naples, Florida.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Stock Exchange OTCMKTSMKTS
Industry Analytical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTSMKTS:OMRX
CUSIPN/A
CIKN/A
WebN/A
Phone914-694-5946
Employees7
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.33 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
30 days | 90 days | 365 days | Advanced Chart

Receive OMRX News and Ratings via Email

Sign-up to receive the latest news and ratings for OMRX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Orthometrix (OTCMKTSMKTS:OMRX) Frequently Asked Questions

What stocks does MarketBeat like better than Orthometrix?

Wall Street analysts have given Orthometrix a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Orthometrix wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are Orthometrix's key executives?

Orthometrix's management team includes the following people:
  • Mr. Reynald G. Bonmati, Founder, Chief Exec. Officer, Pres, Treasurer and Chairman (Age 73)
  • Mr. Arik Avni B.Sc., M.Sc., PT, Chief Technical Officer (Age 61)

Who are some of Orthometrix's key competitors?

What is Orthometrix's stock symbol?

Orthometrix trades on the OTCMKTSMKTS under the ticker symbol "OMRX."

How do I buy shares of Orthometrix?

Shares of OMRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

How many employees does Orthometrix have?

Orthometrix employs 7 workers across the globe.

How can I contact Orthometrix?

The company can be reached via phone at 914-694-5946.


This page was last updated on 3/2/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.